Ines Miranda-Santos

Ines Miranda-Santos

Auto-generated profile, based on publicly available information

Ines Miranda-Santos

CNC ‐ Center for Neuroscience and Cell Biology CIBB ‐ Centre for Innovative Biomedicine and Biotechnology University of Coimbra Portugal

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Trends in Cell Biology
Verified
Journal Article
Closed access
KRKaterina Rohlenova
Katerina Rohlenova
KVKoen Veys
Koen Veys
IMInes Miranda-Santos
Ines Miranda-Santos
KBKatrien De Bock
Katrien De Bock
PCPeter Carmeliet
Peter Carmeliet

14 June 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
RORaimund Oberle
Raimund Oberle
FUFlorian Udonta
Florian Udonta
MWMark Wroblewski
Mark Wroblewski
IBIsabel Ben-Batalla
Isabel Ben-Batalla
ISInes Miranda Santos
Ines Miranda Santos
SLSonja Loges
Sonja Loges
Intrinsic and adaptive resistance hampers the success of antiangiogenic therapies (AAT), especially in breast cancer where this treatment modality has proven largely ineffective. Therefore, novel strategies to improve the efficacy of AAT are warranted. Solid tumors such as breast cancer are characterized by a high infiltration of myeloid-derived suppressor cells (MDSC), which are key drivers of resistance to AAT. Therefore, we hypothesized that all-trans retinoic acid (ATRA), which induces differentiation of MDSC into mature cells, could improve the therapeutic effect of AAT. ATRA increased the efficacy of anti–VEGFR2 antibodies alone and in combination with chemotherapy in preclinical breast cancer models. ATRA reverted the anti–VEGFR2-induced accumulation of intratumoral MDSC, alleviated hypoxia, and counteracted the disorganization of tumor microvessels. Mechanistic studies indicate that ATRA treatment blocked the AAT-induced expansion of MDSC secreting high levels of vessel-destabilizing S100A8. Thus, concomitant treatment with ATRA holds the potential to improve AAT in breast cancer and possibly other tumor types. Significance: Increasing the therapeutic efficiency of antiangiogenic drugs by reducing resistance-conferring myeloid-derived suppressor cells might improve breast cancer treatment. Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/12/3220/F1.large.jpg. Cancer Res; 78(12); 3220–32. ©2018 AACR.

7 March 2022 in The FEBS Journal
Verified
Journal Article
Closed access
CCCláudio F. Costa
Cláudio F. Costa
Cláudia M. M. DeusCláudia M. M. Deus
Cláudia M. M. Deus
SPSonia L.C. Pinho
Sonia L.C. Pinho
IMInês Miranda‐Santos
Inês Miranda‐Santos
GAGonçalo J. M. Afonso
Gonçalo J. M. Afonso
Teresa Cunha-OliveiraTeresa Cunha-Oliveira
Teresa Cunha-Oliveira

18 December 2014 in Analytical Chemistry
Verified
Journal Article
Closed access
IMInes Miranda-Santos
Ines Miranda-Santos
SGSilvia Gramacho
Silvia Gramacho
Marta PineiroMarta Pineiro
Marta Pineiro
KMKarla Martinez-Gomez
Karla Martinez-Gomez
MFMichel Fritz
Michel Fritz
EHElmar Heinzle
Elmar Heinzle

24 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
CCCláudio F. Costa
Cláudio F. Costa
SPSonia L.C. Pinho
Sonia L.C. Pinho
SPSonia L.C. Pinho
Sonia L.C. Pinho
IMInês Miranda-Santos
Inês Miranda-Santos
OBOlivia Bagshaw
Olivia Bagshaw
Teresa Cunha-OliveiraTeresa Cunha-Oliveira
Teresa Cunha-Oliveira
Cell culture conditions highly influence cell metabolism in vitro . This is relevant for preclinical assays, for which fibroblasts are an interesting cell model, with applications in regenerative medicine, diagnostics and therapeutic development for personalized medicine as well as in the validation of ingredients for cosmetics. Given these cells’ short lifespan in culture, we aimed to identify the best cell culture conditions and promising markers to study mitochondrial health and stress in Normal Human Dermal Fibroblasts (NHDF). We tested the effect of reducing glucose concentration in the cell medium from high glucose (HGm) to a more physiological level (LGm), or its complete removal and replacement by galactose (OXPHOSm), always in the presence of glutamine and pyruvate. We have demonstrated that only with OXPHOSm it was possible to observe the selective inhibition of mitochondrial ATP production. This reliance on mitochondrial ATP was accompanied by changes in oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), oxidation of citric acid cycle substrates, fatty acids, lactate and other substrates, mitochondrial network extension and polarization and changes in several key transcripts related to energy metabolism. We also evaluated the relevance of galactose, glutamine and pyruvate for OXPHOS stimulation, by comparing OCR and ECAR in the presence or absence of these substrates. Galactose and pyruvate seem to be important, but redundant, to promote OXPHOS, whereas glutamine was essential. We concluded that LGm does not promote significant metabolic changes but the short-term adaptation to OXPHOSm is ideal for studying mitochondrial health and stress in NHDF. Author Contributions: CC, SAP, SLCP and IMS performed experiments. TCO and PJO designed research and acquired funding. JS, and OB analyzed data. CC and TCO analyzed data and wrote the paper. All authors contributed to the final version of the manuscript.